Financials in GBp. Standardized financial statements.
A compact view of how Redx Pharma Plc turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £4.20M | £18.69M | £10.04M | £5.68M | £3.13M | £129,000 | £30.47M | £0 | £0 | £0 |
| Revenue Growth? | -77.5% | +86.2% | +76.5% | +81.6% | +2327.1% | -99.6% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | £960,000 | £0 | £0 | £0 | £350,000 | £0 | £0 | £262,000 | £0 | £0 |
| Gross Profit? | £3.24M | £18.69M | £10.04M | £5.68M | £2.78M | £129,000 | £30.47M | -£262,000 | £0 | £0 |
| Gross Margin? | +77.2% | +100.0% | +100.0% | +100.0% | +88.8% | +100.0% | +100.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | £35.18M | £37.25M | £29.78M | £13.96M | £9.97M | £9.33M | £17.42M | £14.39M | £9.43M | £4.01M |
| Operating Income? | -£33.82M | -£16.27M | -£19.75M | -£8.27M | -£7.19M | -£10.17M | £1.98M | -£14.95M | -£9.43M | -£4.01M |
| EBITDA? | -£30.03M | -£19.22M | -£19.10M | -£7.52M | -£7.18M | -£9.01M | £13.42M | -£14.06M | -£9.23M | -£3.77M |
| Income Before Tax | -£32.79M | -£17.80M | -£21.44M | -£9.17M | -£6.33M | -£10.15M | £1.65M | -£15.41M | -£8.82M | -£4.26M |
| Income Tax Expense | £368,000 | £201,000 | £133,000 | £45,000 | -£2.02M | -£1.30M | £118,000 | £114,000 | -£650,000 | -£910,000 |
| Net Income? | -£33.16M | -£18.00M | -£21.58M | -£9.21M | -£4.32M | -£8.85M | £1.53M | -£15.52M | -£8.18M | -£3.35M |
| EPS? | £-0.10 | £-0.06 | £-0.08 | £-0.05 | £-0.03 | £-0.07 | £0.01 | £-0.20 | £-0.14 | £-0.05 |
| Diluted EPS? | £-0.10 | £-0.06 | £-0.08 | £-0.05 | £-0.03 | £-0.07 | £0.01 | £-0.20 | £-0.14 | £-0.05 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality